The AIDS Clinical Trials Unit Experience: Clinical Research and Antiviral Treatment
- 1 December 1988
- journal article
- clinical trial
- Published by Elsevier in Nursing Clinics of North America
- Vol. 23 (4) , 697-706
- https://doi.org/10.1016/s0029-6465(22)01430-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Azidothymidine Associated with Bone Marrow Failure in the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1987
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINEThe Lancet, 1987
- AIDS risk-reduction guidelines: A review and analysisJournal of Community Health, 1986
- Promising Results Halt Trial of Anti-AIDS DrugScience, 1986
- Human Immunodeficiency VirusesScience, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985
- Cancer Treatment Research: The Role of the Nurse in Clinical Trials of Cancer TherapyNursing Clinics of North America, 1982